Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1341)
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
15,414
Price
$8.99
Total Value
$138.57K
Shares Held After
16,638,150
% of Holdings
0.1%
IONIS PHARMACEUTICALS INC (IONS)
BERTHELSEN SPENCER R — Director
Shares
8,000
Price
$73.49
Total Value
$587.92K
Shares Held After
156,013
% of Holdings
4.9%
CG Oncology, Inc. (CGON)
Mulay James — Director
Shares
1,310
Price
$60.12
Total Value
$78.76K
Shares Held After
0
% of Holdings
100.0%
CG Oncology, Inc. (CGON)
Mulay James — Director
Shares
654
Price
$60.12
Total Value
$39.32K
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
920
Price
$553.47
Total Value
$509.20K
Shares Held After
40,513
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
760
Price
$552.59
Total Value
$419.97K
Shares Held After
41,433
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,180
Price
$551.57
Total Value
$650.85K
Shares Held After
42,193
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,768
Price
$550.72
Total Value
$973.66K
Shares Held After
43,373
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
732
Price
$549.56
Total Value
$402.28K
Shares Held After
45,141
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,459
Price
$548.53
Total Value
$800.30K
Shares Held After
45,873
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
482
Price
$547.63
Total Value
$263.96K
Shares Held After
47,332
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
470
Price
$546.22
Total Value
$256.73K
Shares Held After
47,814
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
809
Price
$545.51
Total Value
$441.32K
Shares Held After
48,284
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$543.51
Total Value
$239.14K
Shares Held After
49,093
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$541.61
Total Value
$108.32K
Shares Held After
49,533
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
205
Price
$540.43
Total Value
$110.79K
Shares Held After
49,733
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
75
Price
$538.85
Total Value
$40.41K
Shares Held After
49,938
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
598
Price
$553.76
Total Value
$331.15K
Shares Held After
18,876
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
778
Price
$553.10
Total Value
$430.31K
Shares Held After
19,474
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,144
Price
$551.91
Total Value
$631.38K
Shares Held After
20,252
% of Holdings
5.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,200
Price
$550.89
Total Value
$1.21M
Shares Held After
21,396
% of Holdings
9.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
800
Price
$549.87
Total Value
$439.90K
Shares Held After
23,596
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,616
Price
$548.64
Total Value
$886.60K
Shares Held After
24,396
% of Holdings
6.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
465
Price
$547.77
Total Value
$254.71K
Shares Held After
26,012
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
504
Price
$546.54
Total Value
$275.45K
Shares Held After
26,477
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
855
Price
$545.63
Total Value
$466.52K
Shares Held After
26,981
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
560
Price
$543.50
Total Value
$304.36K
Shares Held After
27,836
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
240
Price
$541.61
Total Value
$129.99K
Shares Held After
28,396
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
45
Price
$540.64
Total Value
$24.33K
Shares Held After
28,636
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
74
Price
$539.46
Total Value
$39.92K
Shares Held After
28,681
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
121
Price
$538.52
Total Value
$65.16K
Shares Held After
28,755
% of Holdings
0.4%
Processa Pharmaceuticals, Inc. (PCSA)
Young David — Director
Shares
2,067
Price
$2.22
Total Value
$4.59K
Shares Held After
19,198
% of Holdings
10.8%
Processa Pharmaceuticals, Inc. (PCSA)
Ng George K — Director
Shares
2,465
Price
$2.22
Total Value
$5.47K
Shares Held After
12,435
% of Holdings
19.8%
Processa Pharmaceuticals, Inc. (PCSA)
SKIBSTED RUSSELL — Chief Financial Officer
Shares
2,654
Price
$2.22
Total Value
$5.89K
Shares Held After
13,412
% of Holdings
19.8%
Immuneering Corp (IMRX)
Hall Brett Matthew — CHIEF SCIENTIFIC OFFICER
Shares
6,035
Price
$4.15
Total Value
$25.05K
Shares Held After
382,531
% of Holdings
1.6%
Processa Pharmaceuticals, Inc. (PCSA)
Lin Patrick — Chief Business - Strategy Off
Shares
1,831
Price
$2.22
Total Value
$4.06K
Shares Held After
11,007
% of Holdings
16.6%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
2,322
Price
$72.08
Total Value
$167.36K
Shares Held After
980,073
% of Holdings
0.2%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
82,740
Price
$71.42
Total Value
$5.91M
Shares Held After
982,395
% of Holdings
7.8%
Processa Pharmaceuticals, Inc. (PCSA)
Guy Wendy — Chief Administrative Officer
Shares
2,118
Price
$2.22
Total Value
$4.70K
Shares Held After
11,958
% of Holdings
17.7%
Immunovant, Inc. (IMVT)
Pande Atul — Director
Shares
1,500
Price
$34.02
Total Value
$51.03K
Shares Held After
116,731
% of Holdings
1.3%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
3,666
Price
$3.58
Total Value
$13.12K
Shares Held After
132,715
% of Holdings
2.7%
ABEONA THERAPEUTICS INC. (ABEO)
Silverstein Christine Berni — Director
Shares
18,160
Price
$5.71
Total Value
$103.70K
Shares Held After
119,562
% of Holdings
13.2%
Oruka Therapeutics, Inc. (ORKA)
Sandler Laura Lee — Chief Operating Officer
Shares
600
Price
$69.69
Total Value
$41.81K
Shares Held After
236,384
% of Holdings
0.3%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
733
Price
$69.69
Total Value
$51.08K
Shares Held After
31,034
% of Holdings
2.3%
Ultragenyx Pharmaceutical Inc. (RARE)
Parschauer Karah Herdman — EVP and Chief Legal Officer
Shares
1,899
Price
$24.62
Total Value
$46.75K
Shares Held After
94,462
% of Holdings
2.0%
Ultragenyx Pharmaceutical Inc. (RARE)
Sanders Corazon (Corsee) D. — Director
Shares
2,000
Price
$25.05
Total Value
$50.10K
Shares Held After
21,095
% of Holdings
8.7%
Oruka Therapeutics, Inc. (ORKA)
Klein Lawrence Otto — Director
Shares
1,729
Price
$69.69
Total Value
$120.49K
Shares Held After
925,580
% of Holdings
0.2%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
947
Price
$69.69
Total Value
$66.00K
Shares Held After
32,718
% of Holdings
2.8%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
300
Price
$70.62
Total Value
$21.19K
Shares Held After
33,665
% of Holdings
0.9%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
5,064
Price
$69.42
Total Value
$351.55K
Shares Held After
33,965
% of Holdings
13.0%
Showing 401–450 of 1341 transactions (page 9 of 27)